Brief: Compugen Presents Data Update From Ongoing Phase 1 Trial Of Com701 At The 2020 AACR Virtual Annual Meeting

Compugen

27/04/2020 11:04

April 27 (Reuters) - Compugen Ltd  CGEN.TA :
    * COMPUGEN PRESENTS DATA UPDATE FROM ONGOING PHASE 1 TRIAL
OF
COM701 AT THE 2020 AACR VIRTUAL ANNUAL MEETING
    * COMPUGEN LTD - COM701 WAS WELL-TOLERATED WITH NO
DOSE-LIMITING
TOXICITIES OBSERVED AS A MONOTHERAPY AND IN COMBINATION WITH
OPDIVO
    * COMPUGEN LTD -  ENCOURAGING SIGNALS OF DURABLE DISEASE
CONTROL,
FROM ONGOING PHASE 1 TRIAL OF COM701

Source text for Eikon:  ID:nPn1p2LWMa 
Further company coverage:  CGEN.TA 

 ((Reuters.Briefs@thomsonreuters.com;))